Zostavax® at Minimum Release Specification Approaching Expiry (V211-044)
NCT00681031
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
96
Enrollment
INDUSTRY
Sponsor class
Conditions
Herpes Zoster
Interventions
BIOLOGICAL:
ZOSTAVAX®
Sponsor
Merck Sharp & Dohme LLC